| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.1464-5491.2002.00647.X |
| P698 | PubMed publication ID | 11943000 |
| P2093 | author name string | Richard JL | |
| Sultan A | |||
| Daures JP | |||
| Vannereau D | |||
| Parer-Richard C | |||
| P2860 | cites work | Impact of the American Diabetes Association diagnosis criteria on high-risk Spanish population. IGT Research Group. Impaired glucose tolerance | Q33179232 |
| Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius? | Q40819765 | ||
| Impact of new diagnostic criteria for diabetes on different populations | Q43880867 | ||
| Reduced prevalence of diabetes according to 1997 American Diabetes Association criteria | Q45071426 | ||
| Diabetes in older adults: comparison of 1997 American Diabetes Association classification of diabetes mellitus with 1985 WHO classification. | Q46250441 | ||
| Impaired glucose tolerance and fasting hyperglycaemia have different characteristics. | Q51553905 | ||
| Prevalence of undiagnosed diabetes in three American Indian populations. A comparison of the 1997 American Diabetes Association diagnostic criteria and the 1985 World Health Organization diagnostic criteria: the Strong Heart Study. | Q51555558 | ||
| American Diabetes Association diabetes diagnostic criteria, advancing age, and cardiovascular disease risk profiles: results from the Third National Health and Nutrition Examination Survey. | Q51555562 | ||
| Prevalence of diabetes, impaired glucose tolerance, and impaired fasting glucose in a rural population of Korea, according to 1997 American Diabetes Association and 1985 World Health Organization criteria. | Q51556014 | ||
| Screening for impaired glucose tolerance. Results from a population-based study in 21,057 individuals. | Q51559576 | ||
| Risk of diabetes in the new diagnostic category of impaired fasting glucose: a prospective analysis. | Q51561177 | ||
| Comparison of ADA and WHO screening methods for diabetes mellitus in obese patients. American Diabetes Association. | Q51561727 | ||
| Diagnostic criteria for diabetes mellitus and other categories of glucose intolerance: 1997 criteria by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (ADA), 1998 WHO consultation criteria, and 1985 WHO criteria. World | Q51562228 | ||
| Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. | Q51562831 | ||
| Concordance between the 1997 fasting American Diabetes Association criteria and the World Health Organization criteria in healthy Mexican subjects. | Q51564461 | ||
| Lack of agreement between the World Health Organization Category of impaired glucose tolerance and the American Diabetes Association category of impaired fasting glucose. | Q51567031 | ||
| Comparison of glucose tolerance categories according to World Health Organization and American Diabetes Association diagnostic criteria in a population-based study in Brazil. The Japanese-Brazilian Diabetes Study Group. | Q51567057 | ||
| Fasting plasma glucose in screening for diabetes in the Taiwanese population. | Q51567060 | ||
| The 1997 American Diabetes Association criteria versus the 1985 World Health Organization criteria for the diagnosis of abnormal glucose tolerance: poor agreement in the Hoorn Study. | Q51567520 | ||
| Comparison of the current WHO and new ADA criteria for the diagnosis of diabetes mellitus in three ethnic groups in the UK. American Diabetes Association. | Q51568875 | ||
| Usefulness of revised fasting plasma glucose criterion and characteristics of the insulin response to an oral glucose load in newly diagnosed Japanese diabetic subjects. | Q51569209 | ||
| Comparison of diabetes diagnostic categories in the U.S. population according to the 1997 American Diabetes Association and 1980-1985 World Health Organization diagnostic criteria. | Q51572645 | ||
| Fasting plasma glucose as a screening test for diabetes and its relationship with cardiovascular risk factors in Hong Kong Chinese. | Q51576823 | ||
| Use of fasting blood glucose to estimate diabetes prevalence in epidemiological surveys. | Q51611427 | ||
| Determining diabetes prevalence: a rational basis for the use of fasting plasma glucose concentrations? | Q51614996 | ||
| Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria | Q53998038 | ||
| P433 | issue | 4 | |
| P921 | main subject | World Health Organization | Q7817 |
| obesity | Q12174 | ||
| glucose | Q37525 | ||
| glycobiology | Q899224 | ||
| P304 | page(s) | 292-299 | |
| P577 | publication date | 2002-04-01 | |
| P1433 | published in | Diabetic Medicine | Q15758639 |
| P1476 | title | Diagnosis of diabetes mellitus and intermediate glucose abnormalities in obese patients based on ADA (1997) and WHO (1985) criteria | |
| P478 | volume | 19 |
| Q45988714 | Blood levels of homocysteine, cysteine, glutathione, folic acid, and vitamin B12 in the acute phase of atherothrombotic stroke. |
| Q35856654 | Change in cardio-protective medication and health-related quality of life after diagnosis of screen-detected diabetes: Results from the ADDITION-Cambridge cohort. |
| Q78419821 | Current literature in diabetes |
| Q44548940 | Use of glucose, insulin, and C-reactive protein to determine need for glucose tolerance testing |
Search more.